# Long-term Experience With Abatacept SC in Routine Clinical Practice

> **NCT02090556** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 2954 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02090556
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-26
- **Primary completion:** 2019-01-29
- **Final completion:** 2019-01-29
- **Target enrollment:** 2954 (ACTUAL)
- **Last updated:** 2022-01-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02090556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02090556, "Long-term Experience With Abatacept SC in Routine Clinical Practice". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02090556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*